Motor Neurone Disease Trial, Recruiting NCT07132879 Sponsor: University of Sheffield Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT07132879
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Motor Neurone Disease (MND)
  • People who are currently living in the United Kingdom

Who may not be able to join:

  • No specific exclusion criteria were listed in the official trial information (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chris McDermott, MBChB, FRCP, PhD, University of Sheffield

Phone: +44 114 222 2291

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Sheffield
Registry
ClinicalTrials.gov
Start date
14 December 2024
Est. completion
14 December 2074

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

ALSFRS-r (Revised Amyotrophic Lateral Sclerosis Functional Rating Scale); Coping Index-ALS; EQ-5D-5L (EuroQol 5-Dimension 5-Level); D-12 (Dyspnoea-12); M-HADS-D (Depression subscale of the Hospital Anxiety and Depression Scale); NFI-MND (Neurological Fatigue Index-Motor Neurone Disease); WHOQoLB (World Health Organization Quality of Life-BREF) -Bref stands for 'brief version'; MND-SWS (Motor Neurone Disease Social Withdrawal Scale); RSES (Rosenberg Self-Esteem Scale); GSE (General Self-efficacy Scale)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov